Literature DB >> 11266093

TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.

E Jabłońska1, M Kiluk, W Markiewicz, L Piotrowski, Z Grabowska, J Jabłoński.   

Abstract

Simultaneous evaluation of cytokines and their soluble receptor production and the serum levels can be helpful in understanding the local and systemic immune response of a tumor-bearing host. In the present study we examined serum levels of TNF-alpha, IL-6 and their soluble receptors: sTNFRp55, sTNFRp75 and sIL-6R confronted with their production by the polymorphonuclear neutrophils (PMN) from cancer patients. Examinations were carried out in patients with adenocarcinoma breast cancer and squamous cell carcinoma of the oral cavity and related to the clinical course and to different phases of therapy. Secretion of IL-6, sTNFRp55 and sTNFRp75 by PMN appeared to be dependent on tumor type, clinical progression of disease as well as on therapy, suggesting a significant role of these cells at different phases of the immune response to cancer associated with these mediators. Changes in values of TNF-alpha, IL-6 and their soluble receptors in sera of both cancer groups, dependent on tumor type, clinical progression and cancer therapy, could have a diagnostic and prognostic role in cancer disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266093

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  31 in total

Review 1.  Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.

Authors:  Heike Knüpfer; Rainer Preiss
Journal:  Breast Care (Basel)       Date:  2010-06       Impact factor: 2.860

2.  Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery.

Authors:  Mudit Chowdhary; Jeffrey M Switchenko; Robert H Press; Jaymin Jhaveri; Zachary S Buchwald; Philip A Blumenfeld; Gaurav Marwaha; Aidnag Diaz; Dian Wang; Ross A Abrams; Jeffrey J Olson; Hui-Kuo G Shu; Walter J Curran; Kirtesh R Patel
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

3.  Predictive value of preoperative neutrophil-to-lymphocyte ratio on the prognosis of germ cell testicular tumors.

Authors:  Deniz Bolat; Özgü Aydoğdu; Salih Polat; Serkan Yarımoğlu; İbrahim Halil Bozkurt; Tarık Yonguç; Volkan Şen
Journal:  Turk J Urol       Date:  2016-12-14

4.  Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.

Authors:  Vinicius J Campos; Guilherme S Mazzini; José F Juchem; Richard R Gurski
Journal:  J Gastrointest Surg       Date:  2019-11-19       Impact factor: 3.452

5.  Correlation of levels of IL-6 with tumor burden and receptor status in patients of locally advanced carcinoma breast.

Authors:  Binita Goswami; Pankaj Mittal; Nikhil Gupta
Journal:  Indian J Clin Biochem       Date:  2012-06-20

6.  Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.

Authors:  Cem Mirili; Ali Yılmaz; Serkan Demirkan; Mehmet Bilici; Salim Basol Tekin
Journal:  Int J Clin Oncol       Date:  2019-05-09       Impact factor: 3.402

7.  Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.

Authors:  Mairéad G McNamara; Zarnie Lwin; Haiyan Jiang; Arnoud J Templeton; Gelareh Zadeh; Mark Bernstein; Caroline Chung; Barbara-Ann Millar; Normand Laperriere; Warren P Mason
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

8.  The association between mRNA expression of resistin, TNF- ?, IL-6, IL-8, and ER-? in peripheral blood mononuclear cells and breast cancer.

Authors:  Ghorban Mohammadzadeh; Masome Zare-Moayedi; Fatame Ahmmadpour; Mojtaba Rashidi; Ahmad Ahmadzadeh; Amirahmad Salmasi
Journal:  Turk J Med Sci       Date:  2021-02-01       Impact factor: 0.973

9.  Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis.

Authors:  Yang Liu; Yongde Cao; Leting Xiao; Haijiang Wang
Journal:  Cancer Chemother Pharmacol       Date:  2021-02-21       Impact factor: 3.333

10.  NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer.

Authors:  Claudia Marchetti; Marco D'Indinosante; Carolina Bottoni; Chiara Di Ilio; Stefano Di Berardino; Barbara Costantini; Angelo Minucci; Laura Vertechy; Giovanni Scambia; Anna Fagotti
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.